DSC
Duncker Streett & Co’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $535 | Hold |
11
| – | – | ﹤0.01% | 500 |
|
|
2025
Q1 | $374 | Hold |
11
| – | – | ﹤0.01% | 490 |
|
|
2024
Q4 | $433 | Hold |
11
| – | – | ﹤0.01% | 519 |
|
|
2024
Q3 | $517 | Hold |
11
| – | – | ﹤0.01% | 472 |
|
|
2024
Q2 | $594 | Hold |
11
| – | – | ﹤0.01% | 468 |
|
|
2024
Q1 | $750 | Hold |
11
| – | – | ﹤0.01% | 461 |
|
|
2023
Q4 | $689 | Hold |
11
| – | – | ﹤0.01% | 469 |
|
|
2023
Q3 | $499 | Hold |
11
| – | – | ﹤0.01% | 471 |
|
|
2023
Q2 | $618 | Hold |
11
| – | – | ﹤0.01% | 484 |
|
|
2023
Q1 | $498 | Hold |
11
| – | – | ﹤0.01% | 471 |
|
|
2022
Q4 | $447 | Hold |
11
| – | – | ﹤0.01% | 496 |
|
|
2022
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 448 |
|
|
2022
Q2 | $1K | Hold |
11
| – | – | ﹤0.01% | 459 |
|
|
2022
Q1 | $1K | Hold |
11
| – | – | ﹤0.01% | 460 |
|
|
2021
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 493 |
|
|
2021
Q3 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 494 |
|